Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Elite provider by MediFind in the treatment of Leukemia. His top areas of expertise are Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration.

The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is rated as an Elite provider by MediFind in the treatment of Leukemia. His top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as a Distinguished provider by MediFind in the treatment of Leukemia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Leukemia, Non-Hodgkin Lymphoma, and Bone Marrow Aspiration.

Douglas Gladstone is a Transplant Surgeon in Lake Success, New York. Dr. Gladstone is rated as an Advanced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Hodgkin Lymphoma, and Bone Marrow Aspiration.

Ruthee-lu Bayer is a Transplant Surgeon in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration.

Bradley Goldberg, MD, is an attending physician based at the Monter Cancer Center where he specializes in treating patients with both benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology, and Medical Oncology, Dr. Goldberg maintains an active practice where he focuses on compassionate, personalized, and evidence-based multi-disciplinary care. He is part of the team rotating through the inpatient malignant hematology service at North Shore University Hospital (located on 7 Monti). Dr. Goldberg earned his medical degree at SUNY Downstate College of Medicine. He completed his internal medicine residency and his medical oncology and hematology fellowship at the Northwell Health program located at North Shore University Hospital and Long Island Jewish Medical Center. He is currently an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. He is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Acute Promyelocytic Leukemia, Childhood Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia with Maturation, and Bone Marrow Aspiration.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Advanced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration.

Peihong Hsu is a Pathologist and an Oncologist in New Hyde Park, New York. Dr. Hsu has been practicing medicine for over 43 years and is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Leukocytosis, Sickle Cell Disease, Acute Myeloblastic Leukemia with Maturation, and Acute Myeloblastic Leukemia without Maturation.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Tissue Biopsy.

Stephanie Boisclair, MD, is a bone marrow transplant, cellular therapy, and lymphoma specialist at the R.J. Zuckerberg Cancer Center at Long Island Jewish Medical Center. She is an assistant professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, where she completed her hematology and oncology fellowship. Dr. Boisclair earned her medical degree from the American University of Antigua and completed her internal medicine residency at Memorial Healthcare System in Florida.She is the recipient of the ASCO Conquer Cancer Young Investigator Award for her work on clinical trials aimed at optimizing outcomes in acute myeloid leukemia. Her research focuses on post-transplant relapse and strategies to improve graft-versus-host disease (GVHD) outcomes. Dr. Boisclair is a member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), European Society for Blood and Marrow Transplantation (EBMT), and the American Society for Transplantation and Cellular Therapy (ASTCT). She collaborates with the Leukemia & Lymphoma Society to promote patient education and health literacy around bone marrow transplant and cellular therapies. Her passion for oncology is rooted in a desire to improve not only survival outcomes but also quality of life for individuals navigating cancer diagnoses and treatments.At Northwell, Dr. Boisclair is known for her compassionate, patient-centered approach. She emphasizes shared decision-making and tailoring treatment plans to reflect each patient's goals, values, and life circumstances. Some of the most meaningful moments come when patients feel seen and supported, she says. I remember one patient who, during a particularly anxious time, simply said, 'I'm glad you're here I know I can ask what I need to.' It reminded me how much trust and presence matter in helping people feel safe and cared for during vulnerable moments.She credits Northwell's interdisciplinary model encompassing physicians, advanced practice providers, nurses, transplant coordinators, social workers and financial counselors with helping patients navigate the complex transplant journey.For Dr. Boisclair, the most rewarding part of her work is seeing patients not just survive but thrive. Every patient I care for teaches me something. Their courage through uncertainty motivates me every day to keep pushing forward in clinical care and research. Dr. Boisclair is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Adult T-Cell Leukemia, and Non-Hodgkin Lymphoma.

Jessica Caro is a Hematologist Oncology specialist and a Hematologist in Lake Success, New York. Dr. Caro has been practicing medicine for over 9 years and is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Multiple Myeloma, Febrile Neutropenia, Acute Myeloid Leukemia (AML), and Virus Associated Hemophagocytic Syndrome.

Shams Shakil, MD, PhD, MS, is an attending physician based at the Monter Cancer Center where he specializes in the treatment of patients with benign and malignant hematologic conditions. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Shakil is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Shakil maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. He earned his medical degree from Chittagong Medical College in Bangladesh, his PhD from Hiroshima University School of Medicine and his MS in Medical Informatics from the Oregon Health and Science University. His fellowship in Hematology/Oncology was completed at Brookdale University Hospital Center. Dr. Shakil has a research background in both surgical oncology and radiation oncology. He is an active member of the American Society of Hematology. Dr. Shakil is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Sickle Cell Disease, Anemia, Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration.

David Chitty, DO, MSc is an Attending physician at the Monter Cancer Center where he specializes in malignant hematology with a particular clinical interest in acute leukemias. Board certified in Internal Medicine and Medical Oncology, Dr. Chitty maintains an active practice where he focuses on compassionate, personalized, evidence-based multi-disciplinary care. Dr. Chitty is a graduate of the Northwell Health Medical Oncology Translational Research Fellowship program. Prior to his Hematology/Oncology Fellowship, Dr. Chitty completed a residency in Internal Medicine at Maimonides Medical Center in Brooklyn, NY. A graduate of Nova Southeastern University School of Osteopathic Medicine, Dr. Chitty also earned a Master s in Science degree at the University of Ottawa, Ottawa, Canada in Cellular and Molecular Medicine. His work and research in the fields of medicine and oncology have been published in various peer-reviewed journals.Currently, his primary research interest is in the development and implementation of novel measurable residual disease assays. This work will allow clinicians to better implement targeted therapies into clinical practice for patients with resistant or residual disease following initial treatment. In addition, Dr. Chitty was instrumental in COVID-19 related research and continues to help push forward our understanding of COVID-19 disease in patients with cancer. Dr. Chitty is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Childhood Acute Myeloid Leukemia, Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

An internationally known leader in hematology, A. Samer Al-Homsi, MD, MBA, is system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute, where he also serves as director of faculty and academic affairs in medical oncology.In his position, Dr. Al-Homsi treats patients in need of blood and marrow transplantation for blood cancers and other blood conditions. Dr. Al-Homsi attended medical school at Damascus University Faculty of Medicine, did his residency at Advocate Christ Medical Center in Illinois, and completed a fellowship at UMass Chan Medical School in Worcester, MA. He also received training and practiced in France. He came to Northwell from the Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, where he was executive director of transplantation and cellular therapy. His research efforts throughout his career have focused on innovations that lead to better patient care in blood and marrow transplantation.The poet Kahlil Gibran wrote that work is love made visible, and I believe medicine is love made visible, says Dr. Al-Homsi. Every patient has unique needs, based not just on their specific condition, but also on their cultural background, family situation, and the impact of their disease. We're fortunate at Northwell to have care delivered by a large team that's there to address all those aspects.Dr. Al-Homsi is looking forward to advancing more clinical research at Northwell's Feinstein Institutes for Medical Research and at Cold Spring Harbor Laboratory. That will likely facilitate the development of more therapies that can treat patients, he says, and in a way that's safer and more effective.Dr. Al-Homsi doesn't just focus on the physical effects of conditions like leukemia, lymphoma, and multiple myeloma with decades of patient care, he also knows the tremendous value of a deeper conversation about how cancer is affecting patients mental health and everyday function. His priority is to learn about the patient first and the disease second.That perspective on patient advocacy and approaching each interaction with compassion and love is the same now as it was when he first entered medical school, he recalls. I wanted my life to matter, and to make a difference, he says. I'm not trying to change the world, but I can change patients' lives. I can change their world, and that's incredibly rewarding and meaningful. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Graft Versus Host Disease (GvHD), Multiple Myeloma, Adult T-Cell Leukemia, Chronic T-Cell Leukemia (CTCL), and Bone Marrow Transplant.

Vincent Vinciguerra, MD, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Vinciguerra specializes in treating gastrointestinal cancers and breast cancer. As an attending physician at the Monter Cancer Center, Dr. Vinciguerra focuses on providing compassionate, personalized, and evidence-based care. He also has devoted his career to Cancer Control and Prevention programs. He is the principal investigator for the National Cancer Institute (NCI) supported National Community Oncology Research Program which offers clinical trials and innovative therapies for cancer patients. Dr. Vinciguerra has published over 100 journal articles on cancer drug trials and treatments related to his national and international collaborations. Dr. Vinciguerra earned his medical degree and trained in internal medicine at the Georgetown University Medical Center. He completed training in Hematology/Oncology at New York Hospital. Dr. Vinciguerra is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Vinciguerra is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Familial Colorectal Cancer, and Colorectal Cancer.

Crina Vintila is a Hematologist and an Oncologist in Lake Success, New York. Dr. Vintila is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and ALK-Positive Non-Small Cell Lung Cancer.

Steven R. Savona, MD, is an attending physician based at the Monter Cancer Center where his major clinical interests include blood disorders such as malignant and non-malignant hematology diseases as well as oncology expertise in the areas of diseases of the skin including melanoma, basal cell cancer and squamous cell cancer; he also sees patients with colorectal cancer and pancreas cancer. Dr. Savona maintains an active medical practice focusing on compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Medical Oncology, Hematology and Hospice/Palliative medicine, Dr. Savona is an Assistant Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Savona is an active participant in the Cancer Control Program of the National Cancer Institute sponsored clinical trials based at Northwell. He is an investigator on cancer control studies, studies for the treatment of cancer of the pancreas as well as squamous cancer of the skin. In prior studies, Dr. Savona has addressed issues such as tobacco dependency and smoking cessation, redeveloping life styles and physical activity levels after completion of chemotherapy, the prevention of infections in patients with impaired immunity and prevention of hot flashes in patients on hormonal therapy. Dr. Savona earned his medical degree from Duke University School of Medicine. He completed both his residency in internal medicine and his fellowship in Medical Oncology/Hematology at New York University Medical Center. Dr. Savona is an active member of the American Society of Hematology and the American Society of Clinical Oncology. Dr. Savona is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Malignant Peripheral Nerve Sheath Tumor, Bone Tumor, Melanoma, Thrombocytopenia, and Bone Marrow Aspiration.

Arlene Redner is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Redner is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Optic Glioma, Acute Lymphoblastic Leukemia (ALL), Classical Hodgkin Lymphoma, and Leukemia.

Suchitra Acharya is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Acharya is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Hemophilia A, Hemophilic Arthropathy, Hemophilia B, and Blood Clots.

Anshul Vagrecha is a Pediatric Hematologist Oncology provider in New Hyde Park, New York. Dr. Vagrecha is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Hemophagocytic Lymphohistiocytosis, Multisystem Inflammatory Syndrome in Children (MIS-C), Sickle Cell Disease, and Febrile Neutropenia.